Where It Comes From
Manganese is one of the most abundant metals in the earth's crust, found naturally in rock, soil, and water [1]. It has been used industrially since the 18th century in steel production (where it gives steel strength and hardness) and later in dry-cell batteries, fertilizers, and as an additive in gasoline (methylcyclopentadienyl manganese tricarbonyl, or MMT, was used in unleaded gasoline in Canada and some US states) [2]. The occupational disease was first described in Chilean manganese miners in 1837 by Dr. John Couper, who observed a syndrome of tremors, muscle rigidity, and shuffling gait in miners exposed to manganese dust — a clinical picture almost identical to Parkinson's disease. Modern cases appear primarily among welders exposed to manganese fumes from welding rods, and among ferroalloy plant workers [3]. In water, manganese is released naturally from iron-bearing aquifer sediments, particularly in areas with low-oxygen groundwater, and can exceed health limits in private wells across the eastern US.
How You Are Exposed
The most significant non-occupational exposure pathway for most people is drinking water [1]. Manganese occurs naturally in groundwater, particularly from private wells in the Northeast, upper Midwest, and Southeast. Concentrations can reach levels of concern even where water looks clear and tastes normal — manganese is not always detectable by taste or odor. Infants who drink formula mixed with high-manganese water face proportionally higher exposures because they consume more water per body weight [2]. Food provides modest intake — whole grains, nuts, legumes, and tea all contain manganese naturally. Welding is the critical occupational route: welding with manganese-containing electrodes generates fine fumes that are deeply inhaled and reach the brain far more efficiently than ingested manganese [3]. MMT in gasoline contributed to air emissions in areas where it was used.
Why It Matters
The brain accumulates manganese via the olfactory nerve and bloodstream, depositing it preferentially in the basal ganglia — the same region damaged in Parkinson's disease [1]. This explains why manganism and Parkinson's disease look so similar: both cause tremor, rigidity, slow movements, and balance problems. The key differences are that manganism often causes a characteristic "cock walk" gait, psychiatric symptoms (anxiety, impulsivity, emotional lability) emerge earlier, and the disease can stabilize if exposure stops — unlike Parkinson's [2]. In children, lower-level manganese exposure from drinking water has been associated with reduced IQ, impaired memory, and ADHD-like symptoms — the developing brain is more sensitive to manganese neurotoxicity than the adult brain. The issue is dose: you need some manganese to function, but the line between essential and neurotoxic is narrower than with many nutrients [3].
Who Is at Risk
Welders — especially those who weld in enclosed or poorly ventilated spaces — face the highest risk of manganism [1]. Workers in ferroalloy production, battery manufacturing, and dry-cell battery recycling also have elevated exposures. Infants drinking formula prepared with well water high in manganese are a special concern — the EPA lifetime health advisory for manganese in drinking water is 300 µg/L, but some researchers argue much lower levels (50–100 µg/L) affect children's neurodevelopment [2]. People on private wells in the eastern US, particularly in Maryland, Pennsylvania, and New England, should test for manganese. Individuals with liver disease have impaired manganese excretion and accumulate it more readily [3].
How to Lower Your Exposure
Test your private well for manganese — this is not included in standard municipal water testing reports [1]. If levels exceed 300 µg/L (the EPA health advisory), use a certified filter: greensand filtration, oxidizing filters, or reverse osmosis all remove manganese. Do not prepare infant formula with unfiltered water if your well exceeds 100 µg/L — use bottled water or a certified filter for infant feeding [2]. Welders should use local exhaust ventilation systems that capture fumes at the source, choose low-manganese welding consumables when the application allows, and wear a P100 respirator during confined-space welding. Manganese blood and urine testing can assess current exposure; brain MRI shows manganese deposition in the basal ganglia in exposed workers [3]. If you notice tremor or emotional changes and have occupational manganese exposure, seek neurological evaluation promptly.
References
- [1]Aschner M, Aschner JL. Manganese neurotoxicity: cellular effects and blood-brain barrier transport. Neurosci Biobehav Rev. 1991;15(3):333-40. https://doi.org/10.1016/s0149-7634(05)80026-0
- [2]Bouchard MF, et al. Intellectual impairment in school-age children exposed to manganese from drinking water. Environ Health Perspect. 2011;119(1):138-43. https://doi.org/10.1289/ehp.1002321
- [3]Lucchini RG, et al. Neurological and neurobehavioral effects of manganese. Neurotoxicology. 2012;33(4):549-54. https://doi.org/10.1016/j.neuro.2011.12.010
- [4]EPA. Drinking Water Health Advisory for Manganese. https://www.epa.gov/sites/default/files/2014-09/documents/support_cc1_magnanese_dwreport_0.pdf
Recovery & Clinical Information
Body Half-Life
Manganese from occupational inhalation deposits preferentially in the brain — specifically the basal ganglia (globus pallidus, substantia nigra, striatum) — where it has a biological half-life of months to years [1]. Blood manganese has a shorter half-life (~10-40 days) and normalizes relatively quickly after exposure ends. Brain manganese, measured by MRI, decreases slowly and incompletely after cessation of high-dose exposure [2].
Testing & Biomarkers
Blood manganese is the standard occupational biomarker for recent high-level exposure; background is <15 µg/L whole blood [1]. Urine manganese is less reliable than blood. Brain MRI (T1-weighted hyperintensity in the basal ganglia — the 'manganese-MRI sign') provides direct evidence of brain accumulation and persists even after blood manganese normalizes [2]. Neurological assessment including fine motor testing, olfaction testing, and cognitive screening can detect subclinical manganism [1].
Interventions
Removing the source of manganese exposure is the first step; blood manganese falls and symptoms may stabilize [1]. EDTA chelation mobilizes manganese but its benefit in established neurological disease (manganism) is limited and the safety for brain-accumulated manganese is uncertain [2]. Some studies show L-DOPA partially improves motor symptoms in manganism (given the dopaminergic overlap with Parkinson's disease), though the response is less complete than in Parkinson's [1]. Dietary iron adequacy competes with manganese at gut transporters and reduces manganese absorption — iron deficiency increases manganese absorption [2].
Recovery Timeline
Blood manganese normalizes within weeks to months of stopping high exposure [1]. Brain MRI signal abnormalities can persist for 1-5+ years after exposure cessation; some normalization occurs but may be incomplete [2]. Motor and neurological symptoms (tremor, gait instability, cognitive changes) may improve partially after source removal, especially in early-stage cases, but advanced manganism with established basal ganglia damage tends to be only partially reversible [1].
Recovery References
- [1]Aschner M, Erikson KM (2017). Manganese: a potent neurotoxicant. Encyclopedia of Neuroscience. https://doi.org/10.1016/B978-0-12-809324-5.21326-3
- [2]ATSDR (2012). Toxicological Profile for Manganese. https://www.atsdr.cdc.gov/toxprofiles/tp151.pdf